KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Healthcare (HCA) over the last 16 years, with FY2024 value amounting to $1.9 billion.

  • Healthcare's Cash & Equivalents fell 6547.78% to $997.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $997.0 million, marking a year-over-year decrease of 6547.78%. This contributed to the annual value of $1.9 billion for FY2024, which is 10673.8% up from last year.
  • Per Healthcare's latest filing, its Cash & Equivalents stood at $1.9 billion for FY2024, which was up 10673.8% from $935.0 million recorded in FY2023.
  • Healthcare's 5-year Cash & Equivalents high stood at $1.9 billion for FY2024, and its period low was $908.0 million during FY2022.
  • In the last 5 years, Healthcare's Cash & Equivalents had a median value of $1.5 billion in 2021 and averaged $1.4 billion.
  • In the last 5 years, Healthcare's Cash & Equivalents surged by 18872.79% in 2020 and then tumbled by 3742.25% in 2022.
  • Annual analysis of 5 years shows Healthcare's Cash & Equivalents stood at $1.8 billion in 2020, then dropped by 19.07% to $1.5 billion in 2021, then plummeted by 37.42% to $908.0 million in 2022, then grew by 2.97% to $935.0 million in 2023, then skyrocketed by 106.74% to $1.9 billion in 2024.
  • Its Cash & Equivalents was $1.9 billion in FY2024, compared to $935.0 million in FY2023 and $908.0 million in FY2022.